NU-0129

· Northwestern University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NU-0129, covering 2022-08-26 to 2022-08-26. Get the full timeline:

Most recent: Clinical Trial Update: NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery [EARLY_Phase 1]